A detailed history of Lam Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Lam Group, Inc. holds 59 shares of VTRS stock, worth $693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 59 -0.0%
Holding current value
$693
Previous $627,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

BUY
$8.72 - $11.56 $514 - $682
59 New
59 $657,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Lam Group, Inc. Portfolio

Follow Lam Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lam Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lam Group, Inc. with notifications on news.